In case you missed it: Dec. 7 to Dec. 11
This week’s top articles included:
Reversing endometrial hyperplasia with levonorgestrel-intrauterine system: a Cochrane review
In the largest meta-analysis study to date, researchers find that a levonorgestrel-intrauterine system (LNG-IUS) used for 3 to 6 months is likely more effective than non‐intrauterine progestogens for reversing endometrial hyperplasia (EH).
A look back at 2020
What a year 2020 has been! We hope to look back on it and recognize it as an outlier or anomaly—hoping life will at some point return to normal.
Protocols for High-Risk Pregnancies, 7th Edition
Snapshot: Protocol 56 - Shoulder Dystocia
Managing fetal sex discordance in cfDNA
This article presents a clinical algorithm and four cases to consider.
Lymphangioma circumscriptum
Could you recognize this rare vulvar condition?
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
Unraveling preeclampsia: Insights into heterogeneity and intravascular inflammation
April 22nd 2024A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.
Read More
